Potential Cost Savings Associated with Targeted Substitution of Current Guideline-Concordant Inpatient Agents with Omadacycline for the Treatment of Adult Hospitalized Patients with Community-Acquired Bacterial Pneumonia at High Risk for <i>Clostridioides difficile</i> Infections: Results of Healthcare-Decision Analytic Model from the United States Hospital Perspective

Potential Cost Savings Associated with Targeted Substitution of Current Guideline-Concordant Inpatient Agents with Omadacycline for the Treatment of Adult Hospitalized Patients with Community-Acquired Bacterial Pneumonia at High Risk for <i>Clostridioides difficile</i> Infections: Results of Healthcare-Decision Analytic Model from the United States Hospital Perspective

Introduction: Approximately 3% of hospitalized patients with community-acquired bacterial pneumonia (CABP) develop healthcare-associated <i>Clostridioides difficile</i> infection (HCA-CDI). The validated Davis risk score (DRS) indicates that patients with a DRS ≥ 6 are at an increased ri...

Full description

Bibliographic Details
Main Authors: Thomas Lodise, Mauricio Rodriguez, Surya Chitra, Kelly Wright, Nimish Patel
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Antibiotics
Subjects:
community-acquired pneumonia
antibiotics
omadacycline
<i>Clostridioides difficile</i> infection
Online Access:https://www.mdpi.com/2079-6382/10/10/1195

Similar Items

Similar Items